155 related articles for article (PubMed ID: 35167611)
1. Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.
Wang SW; Chan LP; Wang LF; Wu CW; Lin SH; Huang TY; Lee KW
PLoS One; 2022; 17(2):e0263773. PubMed ID: 35167611
[TBL] [Abstract][Full Text] [Related]
2. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
3. Outcomes for patients with second primary malignancy after primary surgical treatment for early-stage squamous cell carcinoma of the oral cavity.
Suton P; Prpic M; Tarle M; Mamic M; Nikles I; Luksic I
Head Neck; 2018 Nov; 40(11):2347-2352. PubMed ID: 30302872
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
6. Time-varying association of second primary malignancy and long-term survival outcomes in patients with head and neck cancer.
Zhu X; Heng Y; Zhou J; Lin H; Zhou L; Zhang M; Cao P; Tao L
Int J Cancer; 2023 Jul; 153(1):94-102. PubMed ID: 36946652
[TBL] [Abstract][Full Text] [Related]
7. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
8. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
9. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.
Li X; Guo K; Feng Y; Guo Y
Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661
[TBL] [Abstract][Full Text] [Related]
10. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
11. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
12. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
13. Second primary malignancies in patients with cancer of the head and neck.
Vaamonde P; Martín C; del Río M; LaBella T
Otolaryngol Head Neck Surg; 2003 Jul; 129(1):65-70. PubMed ID: 12869919
[TBL] [Abstract][Full Text] [Related]
14. Second primary cancer after index head and neck squamous cell carcinoma in Northern China.
Feng Z; Xu QS; Qin LZ; Li H; Huang X; Su M; Han Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):95-102. PubMed ID: 27720651
[TBL] [Abstract][Full Text] [Related]
15. Incidence of second primary malignant neoplasm in Malwa region of central India.
Naik A; Bhandari V; Saadvik RY; Gupta KL; Kausar M; Batra M
J Cancer Res Ther; 2018; 14(5):999-1004. PubMed ID: 30197338
[TBL] [Abstract][Full Text] [Related]
16. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
18. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
19. Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
Wang L; Feng Z; Wu H; Zhang S; Pu Y; Bian H; Wang Y; Guo C
Tumour Biol; 2014 Nov; 35(11):10977-85. PubMed ID: 25091574
[TBL] [Abstract][Full Text] [Related]
20. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
